Oruka Therapeutics (ORKA) shares outstanding

Shares outstanding · fiscal 2025
45.61M

Oruka Therapeutics (ORKA) had 45.61M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 21.8% higher than the 37.44M of fiscal 2024. Figures as of 18 Nov 2026, 12:00 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
45.61M
Change on fiscal 2024
+21.8%
Highest on record
45.61Mfiscal 2025
Lowest on record
1.11Kfiscal 2011
Fiscal years on record
92011–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Oruka Therapeutics shares outstanding, in more detail

The market data feed counts 67.82M shares outstanding today.

Across the 9 fiscal years on record (2011–2025), the highest was 45.61M in fiscal 2025 and the lowest 1.11K in fiscal 2011.

History · 9 fiscal years

Shares outstanding by fiscal year

Oruka Therapeutics shares outstanding, year by year

Oruka Therapeutics (ORKA) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
202545.61M 21.8% up
202437.44M 3,016.6% up
20231.20M 0.0% up
20221.20M 3.6% up
20211.16M—
201413.56K 137.5% up
20135.71K 287.7% up
20121.47K 32.8% up
20111.11K—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of Oruka Therapeutics and comparable companies
CompanyShares outstandingFiscal year
Immunovant IMVT182.42M2026
Axsome Therapeutics AXSM49.75M2025
Chemed CHE14.46M2025
Oruka Therapeutics ORKA45.61M2025
Arrowhead Pharmaceuticals ARWR141.29M2026
MSA Safety MSA39.35M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ORKA

Oruka Therapeutics, figure by figure

Oruka Therapeutics (ORKA) overview: price, valuation and scorecardAll health care companies by market value

Oruka Therapeutics shares outstanding: questions and answers

How many shares does Oruka Therapeutics have?

Oruka Therapeutics (ORKA) had 45.61M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 21.8% higher than the 37.44M of fiscal 2024. The market data feed counts 67.82M shares outstanding today.

What are the highest and lowest diluted share count figures on record for Oruka Therapeutics?

Across the 9 fiscal years on record (2011–2025), the highest was 45.61M in fiscal 2025 and the lowest 1.11K in fiscal 2011.

How is Oruka Therapeutics's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Oruka Therapeutics it is on record here for 9 fiscal years, 2011 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Oruka Therapeutics (ORKA) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/ORKA/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.